Proprotein Convertase Subtilisin/Kexin Type 9 May Associate With Lipoproteins Through Lipid Interactions

被引：0
|
作者：
Sarkar, Samantha K.
Goto, Natalie
Lagace, Thomas A.
机构：
来源：
CIRCULATION | 2016年 / 134卷
关键词：
PCSK9; LDL; Lipoproteins; Lipids;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
19863
引用
收藏
页数：7
相关论文
共 50 条
  • [41] Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition and the Future of Lipid Lowering Therapy
    Joseph, Lee
    Robinson, Jennifer G.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2015, 58 (01) : 19 - 31
  • [42] Proprotein convertase subtilisin/kexin type 9 (PCSK9) in lipid metabolism, atherosclerosis and ischemic stroke
    Zhang, Lingling
    Song, Kangping
    Zhu, Mengting
    Shi, Jinling
    Zhang, Huijuan
    Xu, Liang
    Chen, Yingzhu
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2016, 126 (08) : 675 - 680
  • [43] Proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors
    Leong, Derek
    Wu, Peter E.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2019, 191 (32) : E894 - E894
  • [44] PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9): A Narrative Review
    Dua, Pamila
    Reeta, K. H.
    JOURNAL OF THE PRACTICE OF CARDIOVASCULAR SCIENCES, 2020, 6 (03) : 226 - 233
  • [45] Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Lipid Reduction: A Network Meta-Analysis
    Shen, Hua
    Chai, Meng
    Zhou, Yujie
    CIRCULATION, 2024, 150
  • [46] The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in HyperlipidemiaFocus on Therapeutic Implications
    Michel Farnier
    American Journal of Cardiovascular Drugs, 2011, 11 : 145 - 152
  • [47] The role of proprotein convertase subtilisin/kexin type 9 inhibitors in clinical practice
    Blanquez Martinez, David
    Hayon Ponce, Maria
    Caballero Romero, Alvaro
    Nieto Gomez, Pelayo
    Diaz Villamarin, Xando
    Alvarez Sanchez, Raquel
    Cabeza Barrera, Jose
    Davila Fajardo, Cristina
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (01) : 302 - 302
  • [48] Proprotein convertase subtilisin/kexin type 9: from genetics to clinical trials
    Stoekenbroek, Robert M.
    Kastelein, John J. P.
    CURRENT OPINION IN CARDIOLOGY, 2018, 33 (03) : 269 - 275
  • [49] Statins Induce Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9
    Lagace, Thomas A.
    Bashmakov, Yuriy
    Anderson, Norma N.
    McNutt, Markey C.
    Grefhorst, Aldo
    Ho, Y. K.
    Horton, Jay D.
    FASEB JOURNAL, 2008, 22
  • [50] Proprotein convertase subtilisin/kexin type 9: an update on the cardiovascular outcome studies
    Ferri, Nicola
    Grego, Maria Francesca
    Corsini, Alberto
    Ruscica, Massimiliano
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0E) : E64 - E67
12345